Metabolism and transport of the cyclin-dependent kinase inhibitor flavopiridol in human liver and carcinoma cell lines: impact on therapy

    Aktivität: VorträgeVortragAndere

    Zeitraum16 Mai 2006
    Gehalten amPoznan University of Medical Sciences, Polen